I
nfection is a very rare cause of primary or secondary adrenal insufficiency (AI) (1, 2) . However, numerous studies have reported wide ranges in the actual incidence of AI in patients with sepsis (3) (4) (5) (6) . Part of the problem exists in the definition of AI. Classically, the definition of AI is both 30-and 60-min cortisol concentration Ͻ20 g/dL after a 250-g dose of ACTH administration (intravenous or intramuscular) (1, 2) . Although most references use the maximum cortisol of 20 g/dL (1, 2), 18.0 g/dL and 18.1 g/dL (500 nmol/L in European literature) also have been used as cutoff values.
The change in serum cortisol or the delta cortisol response has been used as an additional criterion for the diagnosis of AI (2) . Using a cortisol response of Ͻ7.3 g/dL (200 nmol/L) in one publication, the authors reported that 52% of patients with septic shock met this criterion for AI (3) . In comparison, only 9% of the patients who failed to increase serum cortisol above 19.9 g/dL met the historical criterion for AI (3) . In a second study, using a cortisol response of Ͻ9.0 g/dL (250 nmol/L), these authors estimated that the incidence of AI was as high as 47% of patients with septic shock (4) . However, when the authors used the criterion of a maximal cortisol Ͼ19.9, only 9.3% of patients met this criterion for AI. In a large study, 54% of the patients failed to increase cortisol by 9.0 g/dL, but only 11.1% met the classic criterion that the maximal cortisol concentration must be Ͻ20 g/dL to diagnosis AI (5) (D. Annane, personal communication) .
In the setting of sepsis, authors have used many different delta cortisol responses to identify their population. In general, there is no acceptable cutoff for the delta cortisol increase post-ACTH. However, most endocrinologist agree that all patients' maximum cortisol should exceed 19.9 g/dL. In those patients who do not exceed 19.9 g/dL in the setting of severe sepsis, many would be considered to have AI. In this study, only the maximal cortisol concentration was used in the diagnosis of AI. If all three cortisol concentrations were Ͻ20 g/dL, then the patients met the criterion to diagnose AI.
Elimination of the delta cortisol response criterion greatly reduced the incidence of adrenal insufficiency in this population of patients. For example, if we used a delta cortisol response of Ͻ13 g/dL, then 50% of the patients in the current study would meet the criteria for AI. If we used a lower cutoff of 7.3 g/dL, then only 20% of the patients might have been diagnosed as having AI. However, because there is no acceptable standard for the delta cortisol response in patients with sepsis, we elected not to use the delta cortisol response in the diagnosis of AI.
Occult AI may present in the emergency room with the exact signs of sepsis. In patients with early sepsis, 5% of patients (six of 113 patients) with systemic inflammatory response syndrome (SIRS) had cortisol concentrations Ͻ20 g/dL after a 250-g ACTH stimulation test (6) . In a sicker population of patients, 9% of pediatric patients (3) and 9.3% of adult patients with septic shock had all cortisol concentrations Ͻ20 g/dL after a 250-g ACTH stimulation test (5) .
None of the previous studies in patients with sepsis or septic shock determined if AI is secondary in nature. The purpose of this study was three-fold: a) to determine whether AI was located at the pituitary-hypothalamus (secondary AI); b) to identify if the baseline serum cortisol before ACTH influences the delta cortisol response; and c) to confirm that approximately 10% of patients with severe sepsis fail to increase serum cortisol Ͼ19.9 g/dL after ACTH testing.
METHODS
Study Sample. One hundred patients with severe sepsis were prospectively enrolled into a clinical trial to determine the incidence of primary, secondary, or sepsis-associated adrenal insufficiency. The protocol was approved by the Institutional Review Board and General Clinical Research Center Advisory Board. Informed consent, or waiver of consent, was obtained in all patients. These data report the first 100 patients studied in a larger prospective, randomized, double-blind clinical treatment trial.
Patients were included into the clinical trial if they had bacteremia, severe sepsis, or septic shock. The definition of SIRS requires two of the four criteria listed: a) temperature Ͼ38°or Ͻ36°; b) heart rate Ͼ90 beats/min; c) respiratory rate Ͼ20 breaths/min or PaCO 2 Ͻ32 mm Hg; and d) white blood cell count Ͼ12,000/mm 3 , Ͻ4000/mm 3 , or Ͼ10% immature (band) forms. Sepsis was considered present when the patient had two or more of the SIRS criteria and a suspected site of infection. Bacteremia was defined as a positive blood culture. Severe sepsis was defined as sepsis with organ dysfunction, inadequate perfusion, or hypotension. Abnormalities could include, but were not limited to, lactic acidosis, oliguria, and/or an acute altered mental status. Septic shock was defined as hypotension (systolic blood pressure Ͻ90 mm Hg or a Ն40 mm Hg reduction from the baseline) after 500 mL of normal saline fluid intravenous bolus.
Exclusion Criteria. Patients were excluded if they had known primary or secondary adrenal insufficiency, AIDS (due to the fact that many may have received prior glucocorticoid treatment), acute myocardial infarction, or a history of glucocorticoid use for Ͼ14 days within the last year. We also excluded children (Ͻ18 yrs old) and any patient with a do-notresuscitate order.
Definition of Terms. Glucocorticoid insufficiency (GI) was defined as all serum cortisol concentrations Ͻ20 g/dL after a 250-g dose of ACTH. Secondary adrenal insufficiency was defined as GI and a doubling of serum aldosterone concentration (or a concentration Ͼ150 pmol/L) after the ACTH administration. Primary adrenal insufficiency involved GI with an elevated ACTH. Sepsis-associated adrenal insufficiency or dysfunction was GI with a normal or reduced ACTH concentration at baseline and reduced aldosterone response to 250-g dose of ACTH.
Severity of Illness. Acute Physiology and Chronic Health Evaluation (APACHE) III scores were determined on all the patients at the day of entry to the study (7) . This score uses 18 variables to calculate a severity of injury score that is related to hospital survival. The higher the score, the worse the prognosis.
ACTH Testing Protocol. All patients were identified as meeting the criteria for bacteremia, severe sepsis, or septic shock. After informed consent, baseline blood samples were obtained and the patients had a rapid intravenous administration of 250 g of ACTH (1-24; Cortrosyn, Organon, West Orange, NJ). Subsequent blood was obtained at 30 and 60 mins. One hundred patients were entered into and completed the ACTH testing protocol.
Routine Lab Analysis. Zero time blood was analyzed for ACTH, aldosterone, and cortisol. Blood was collected for cortisol and aldosterone at 30 and 60 mins and placed on ice. Samples were allowed to clot and then were separated and placed in plastic vials for analysis. The samples were taken to the lab, and an antibody-coated tube assay (ICN Diagnostics, Irvine, CA) was used to assay cortisol concentrations within a 2-hr period. The low coefficient of variation for the cortisol assay was 4.5%, and the high coefficient of variation was 3.0%. At a later date, serum aldosterone was measured by using a radioimmunoassay kit (ICN Diagnostics, Diagnostic Systems Lab). The aldosterone assay was run in duplicate on the nine patients, ten controls, and 56 of the other 91 septic patients studied. ACTH was assayed on EDTA plasma collected at time 0, spun, separated into 500-L samples, and frozen at Ϫ70°. The samples were analyzed by the chemiluminescence assay (Nichols Labs, Kit 100T, 60 -4175, San Clemente, CA) on an Auto Clini-Lumat LB952T/16 (Berthold Systems, Pittsburgh, PA) with a sensitivity of 1 pg/mL. 
RESULTS

Patient Characteristics and Serum
Cortisol and Aldosterone Responses. Forty-nine of the 100 patients were female. Five of the nine patients with the failed ACTH stimulation test were female. Table  1 lists other patient characteristics and ACTH concentrations. Table 2 lists the cortisol and Table 3 the aldosterone results of the 250-g ACTH stimulation test. Nine of the 100 patients did not increase serum cortisol to a concentration of Ն20.0 g/dL after ACTH administration. None of the nine had an elevated ACTH concentration (primary AI). Four of the nine patients had a normal aldosterone response to ACTH indicating secondary AI. Two of these had a history of amenorrhea and very low ACTH concentrations (0 and 3.8 pg/mL), and they responded well to hydrocortisone treatment. Blood pressure increased in both these women within 1 hr of starting hydrocortisone treatment. In one patient, the house staff were unsure of the importance of hydrocortisone treatment. Discontinuing the treatment resulted in a return of the hypotension, which resolved when hydrocortisone was restarted. Five of the nine patients had no aldosterone response to ACTH suggestive of sepsis-associated adrenal insufficiency. The absence of an elevated ACTH in this group excludes the diagnosis of primary AI.
Severity of Injury. The APACHE III score in the nine patients with GI was not different from the 91 with sepsis and normal adrenal function (Table 1) . APACHE III score was inversely related to delta cortisol (r ϭ Ϫ.31, p Ͻ .01). The APACHE III score was the highest (60 Ϯ 4) in the patients with the lowest cortisol response (Ͻ13 g/dL) to ACTH. Patients with an intermediate cortisol response (13.0 -25.9 g/dL) had an intermediate APACHE III score (46 Ϯ 5, p Ͻ .05). Those patients with the greatest cortisol response (Ͼ25.9 g/dL) had the lowest APACHE III score (37 Ϯ 6, p Ͻ .05).
Hospital Mortality Rate in Patients With Glucocorticoid Insufficiency. Four of the nine patients with GI were treated with glucocorticoids, and three survived their hospital stay. On the other hand, five were not treated with glucocorticoid therapy and three survived their hospital stay. The decision not to treat these patients was made by the attending physician. This was mostly due to the concern of the attending physician about the risk of the treatment with glucocorticoids in someone who had severe sepsis vs. the potential benefit of treatment with glucocorticoids.
In total, three of nine patients with GI died in the hospital. Two had not been given hydrocortisone therapy at the discretion of the attending staff who were made aware of the patients' reduced cortisol response to ACTH. The first patient had a baseline cortisol of 16.8 g/dL and reached a maximum of 19.7 g/dL after ACTH administration. The second patient who died had a baseline cortisol of 15.0 g/dL and a maximum of 19.1 g/dL after the ACTH stimulation test. Both patients had bacteremia and alcoholic liver disease. The third person had a baseline cortisol of 16.9 g/dL and reached a maximum of 17.1 g/dL. This person was started on hydrocortisone the same day that he died of septic shock. This patient, like the other two previously described, had bacteremia and alcoholic liver disease.
Baseline Cortisol and Aldosterone Concentrations and Response to ACTH.
The delta cortisol response to ACTH averaged 4.5 Ϯ 1.2 g/dL. In the septic patients, the average response to ACTH was 18.2 Ϯ 4.3 g/dL, similar to normal volunteers ( Table 2 ). The delta cortisol response was similar at a wide range of baseline (time 0) cortisol concentrations (0 -9.9, 10 -19.9, 20 -29.9, 30 -39, 40 -174 g/dL; Table 4 ).
Serum aldosterone concentrations were reduced at time zero in patients with sepsis-associated AI or secondary AI (Table 3) . Only patients with sepsisassociated AI had an absent aldosterone response to ACTH administration. Patients with secondary AI had a normal aldosterone response to ACTH.
Clinical History and Physical Signs of Primary or Secondary Adrenal Insufficiency in Patients With
Sepsis. Seven of the nine patients had anorexia and weight loss before presentation with sepsis. The average weight loss was 20 Ϯ 8 lb (range, 5-40 lb). Six of the nine patients complained of abdominal pain and five of the nine had an episode of vomiting. Three of the patients had fever on admission and four on the day of entry into the study.
Seven of the nine patients had a systolic blood pressure Ͻ110 mm Hg. Five of the nine had systolic blood pressure Ͻ90 mm Hg. The cortisol response to ACTH was similar in those with hypotension compared with normal blood pressure. Symptoms of shock were seen in three of the nine patients. Confusion or stupor was seen in three of the nine patients. Two of the patients had absent axillary hair suggestive of pituitary insufficiency.
Laboratory Signs of Primary or Secondary Insufficiency in Patients With
Sepsis. Six of the nine GI patients had hyponatremia on enrollment. In contrast, only one patient had a potassium concentration that was elevated on enrollment into the study, and one patient had an elevated potassium on admission. Serum sodium and glucose were reduced in GI (Table 5) . No one had classic hypoglycemia (Ͻ40 mg/dL), but five of the seven nondiabetic patients with GI had a blood glucose concentration Ͻ100 mg/dL. Other laboratory measurements were similar in the two groups ( Table 5 ). The total eosinophil count was Ն400 in three of the nine patients.
Seven of the nine patients had pneumonia and two had abdominal infections as their primary source of sepsis. Organisms included four cases of Escherichia coli, two Staphylococcus aureus, one Pseudomonas, one Mycobacterium TB, and one Enterobacter fecalis infection. Organ system failure, as described by Knaus (7), was seen in all five organ systems (cardiovascular, respiratory, renal, hematologic, and neurologic). Organ system failure (i.e., end organ damage) was seen in seven of the nine patients. Two patients had end organ damage in three organs, three with damage in two organs and two with damage in one organ. Three of nine were on vasopressor therapy at the time of enrollment into the study. 
DISCUSSION
In 100 patients, we failed to identify a single patient with the classic definition of Addison's disease (i.e., all serum cortisol concentrations Ͻ20 g/dL and an elevated ACTH). However, we identified that 9% of patients failed to increase serum cortisol Ͼ19.9 g/dL (i.e., had GI). Four of the nine patients had pituitary disease. Five of the nine patients failed to increase serum cortisol as well as aldosterone concentrations, which appears to be due to adrenal dysfunction since ACTH concentrations at baseline were not elevated. Although prolonged ACTH exposure is known to suppress aldosterone secretion (8), it should not reduce the cortisol response to ACTH. Therefore, adrenal dysfunction is a likely cause of the reduced serum cortisol response to ACTH.
The 9% value for GI in the current study was similar to a recent publication of 189 patients with septic shock, where 11.1% of the patients met the 19.9 g/dL criteria of GI (5) (personal communications). The 9 -11% incidence of GI may be an overestimation because a decreased cortisol response can increase to normal after recovery from sepsis (9) . Four of 20 patients who met the criteria for GI recovered their adrenal response to ACTH after resolution of their sepsis (9). Although not tested in this study, three of the five patients who had GI and were not treated with glucocorticoids likely had recovery of their adrenal response to ACTH.
The ACTH and cortisol response to a corticotropin releasing hormone (CRH) stimulation test (100 g) is similar in patients with sepsis, patients undergoing major surgery, and normal volunteers (10) . Although the ACTH release from CRH is similar, nonsurvivors have a reduced cortisol response to CRH (10) . After we exclude the 2% of the patients in our study with occult hypothalamicpituitary disease, these data suggest that most of patients with sepsis had an intact hypothalamic-pituitary (CRH-ACTH) axis.
Primary Adrenal Disease vs. Adrenal Dysfunction in Sepsis and Septic Shock.
A failure to increase cortisol by Ն13.0 g/dL after ACTH is an indicator of a poor survival in SIRS (6) and septic shock (11) . Patients with a 13, 9, or 7.3 g/dL response to ACTH have been classified as having AI (3) (4) (5) (6) 11) . A better term may be adrenal dysfunction. If we use 13 g/dL as the cutoff, 40% of patients with SIRS have adrenal dysfunction (6) . Mortality rate was 42% in patients with adrenal dysfunction compared with 24% with a delta cortisol response between 13.0 and 25.9 g/dL (6). Mortality rate was only 8% for those who had a delta cortisol response of 26 Նg/dL. The greater adrenal function may suggest the absence of adrenal inhibiting factors. In the SIRS population, the APACHE II score was similar in these groups (11 Ϯ 0.9, 9.7 Ϯ 1.0, and 9.1 Ϯ 1.1) (6).
In addition to our earlier data, Moran et al. (11) reported that the breakpoint for a 50% mortality rate in patients with septic shock was at a delta cortisol response of 13.4 g/dL. The lower the delta cortisol response, the greater the mortality rate. For example, mortality rate was 60% at a delta cortisol response of only 9.1 and 80% if there was no cortisol response to 250 g of ACTH. In comparison, mortality rate was Ͻ25% when the delta cortisol response was Ͼ25.9 g/dL (11). In a second study of septic shock, those patients who had a delta cortisol response of Ͻ9.1 g/dL had a 60% mortality rate (5). This was similar to the 80% mortality rate seen previously (11) . Mortality rate was only 27% in those who increased their cortisol by Ͼ9 g/dL (5). In a third study, there was 100% mortality rate in patients with a delta cortisol response of Յ9.1 g/dL and only a 32% mortality rate if the response was Ͼ9.0 g/dL (4). These data support the hypothesis that adrenal dysfunction may influence survival. In the current study, the severity of injury was inversely associated with the delta cortisol response (r ϭ Ϫ.31, p Ͻ .05). The sicker the patients, the smaller the cortisol response to ACTH.
Cortisol Response to ACTH Is Not Reduced in Septic Patients With an Elevated Serum Cortisol Concentration.
The delta cortisol response in 113 patients with SIRS/sepsis was not influenced by the baseline cortisol concentration (Table  3 ). In comparison, one retrospective study demonstrated that the delta cortisol response decreases as baseline cortisol increases (12) . Unfortunately, this study did not identify the patient's diagnosis. The number of patients with sepsis may have been low (12) . In severe sepsis, the delta cortisol response was similar with a wide range of baseline cortisol concentrations (13) . This is similar to our data (Table 3) where baseline cortisol concentration had little influence on delta cortisol response. Patients with sepsis who have a high baseline cortisol concentration (51 Ϯ 5 g/dL) can have a normal (17-24 g/dL) cortisol response to ACTH (14) . Therefore, the absolute cortisol response (0 -26 g/dL) does not appear to be reduced by an elevated serum cortisol concentration at the start of an ACTH stimulation test (Table 4) .
Etiology of Reduced Adrenal Responsiveness to ACTH in Sepsis.
The reduced cortisol response to ACTH may be due to a) decreasing ACTH concentrations during sepsis; b) hypotension/severity of illness as determined by APACHE score; or c) an inhibition of the adrenal gland function due to ACTH receptor-mediated blocking peptides (corticostatin or defensin human neutrophil polypeptide-4).
Classic Addison's disease due to infection is quite rare (1) . This may be because ACTH concentrations decrease after the onset of sepsis and are generally normal or low (15) (16) (17) (18) . It is unlikely that ACTH concentrations observed in classic Addison's disease would fall within the normal range during sepsis. None of the nine patients had an elevated ACTH, which would be expected to be seen in classic primary AI.
Patients with systolic blood pressure Ͻ90 mm Hg had a similar cortisol response to ACTH as those with normal blood pressure. Reduced adrenal responsiveness may be mediated by a class of peptides known as defensins (corticostatins or human neutrophil polypeptide-4) (19, 20) . Corticostatins increase 20-fold in plasma, ten-fold in adrenal tissue, and five-fold in the hypothalamus of rabbits during bacterial infection (21) . It is possible that the blunted cortisol response to ACTH may be due to the presence of this peptide, which is known to inhibit adrenal ACTH binding and corticosterone production (19) . Patients with sepsis have elevations in plasma defensin concentration (22) , but an antibody to human neutrophil polypeptide-4 has not been tested in humans to date.
ACTH-like peptides also have been demonstrated to exist in an animal model of septic shock that inhibit adrenal function (23) . Lymphocytes exposed to lipopolysaccharide produce substances that decrease the adrenal cells' response to ACTH (24) (25) . Mononuclear cells also produce a minor amount of intact ACTH and a major amount of . It is possible that specific types of infections may elucidate responses in the immune response that produce an abundant amount of ACTH-like peptides that could inhibit intact ACTH activity. For patients who recover from sepsis, the cortisol response returns to normal (9) .
Recently, transforming growth factor ␤-1 was shown to inhibit cortisol and aldosterone production in human adrenal cells (33) . This could be one of the factors acting at the adrenal gland to contribute to adrenal dysfunction. Other than a few studies, very little evidence exists that cytokines influence the cortisol production at the adrenal gland. Almost all of the published literature suggests that several cytokines (interleukin [IL]-1, IL-6, tumor necrosis factor-␣, etc.) influence the release of ACTH at, or above, the pituitary gland. For example, corticotrophin releasing factor is stimulated by IL-1 and IL-6, which are mediated by eicosanoid cyclooxygenase pathway. In septic shock, tumor necrosis factor-␣, IL-6, and other cytokine concentrations are increased (16) . ACTH administration has no effect on IL-6, but tumor necrosis factor-␣ concentrations decrease acutely with ACTH administration (16) . Macrophage migration inhibitory factor concentrations also decrease with ACTH administration (27) . Macrophage migration inhibitory factor displays a proinflammatory response and is elevated in sepsis but not in trauma (18) . In both sepsis and in trauma, serum cortisol decreases little over the first 2 wks, but ACTH concentrations abruptly decrease within 4 -6 days of the injury (18, 20) . Although macrophage migration inhibitory factor is proinflammatory, the factor responsible for the decrease in serum ACTH concentration that occurs within the first 4 -6 days of sepsis or trauma is unknown.
Treatment With Hydrocortisone. Three of the four patients treated with hydrocortisone had an improved blood pressure response to hydrocortisone and survived. One of the patients treated died on the first day that hydrocortisone was started. In the other three patients, the systolic/diastolic blood pressure before treatment was very low (70 Ϯ 6/48 Ϯ 10 mm Hg; mean Ϯ SEM) and improved after 24 hrs of treatment (93 Ϯ 7/48 Ϯ 4 mm Hg). On the second day of treatment, blood pressure remained increased (83 Ϯ 7/57 Ϯ 14 mm Hg). These patients recovered from their septic shock and were discharged to their homes on hydrocortisone treatment.
However, five patients were not treated with hydrocortisone and two died. The maximum cortisol in the three survivors (15.5, 18 .0, and 18.1 g/dL) was similar to the maximal cortisol in the two patients who died (15.7 and 19.7 g/dL). However, the delta cortisol response was 13.4, 10.7, and 4.3 in the survivors and only 2.8 and 4.9 g/dL in the two patients who died.
In 41 patients with septic shock who did not have AI, hydrocortisone treatment (approximately 300 mg/day) reversed shock by day 7 more frequently (68% vs. 21%). Mortality rate was reduced from 63% to 32%, but this failed to reach statistical significance (28) . In a second study of 40 patients with septic shock, hydrocortisone treatment reduced the median time to reverse the shock from 7 to 2 days (29). Mortality rate was not significantly reduced on hydrocortisone (20 vs. 30%), but the mortality rate in the placebo arms was higher in the earlier study (30 vs. 63%). The higher mortality rate was likely due to the patients' older age (60 vs. 49 yrs) and fact that the hydrocortisone treatment was started 6 days after vasopressor therapy compared with starting within 3 days of vasopressor therapy (28, 29) . Recent work demonstrated that mortality rate is reduced in septic shock patients with adrenal dysfunction who receive hydrocortisone and fludrocortisone for a 7-day period (63% to 53% mortality rate) (30 (4 -6, 11, 13, 15-17, 31, 32) . Patients with bacteremia or septic shock (4 -6, 11, 13, 15, 16) have a smaller delta cortisol response to a 250-g intravenous dose of ACTH compared with patients with SIRS (9.5 Ϯ 1.6 vs. 19.0 Ϯ 2.0 g/ dL; p Ͻ .05; Table 6 ). Patients with bacteremia also have a smaller response to ACTH (6) . There may be a relationship between bacteremia or sepsis and a reduced delta cortisol response. The reduced delta cortisol response returns to normal after recovery from septic shock (7.7 g/dL to 14.7 g/dL) (9) . This might explain why we identified 5% of patients with sepsis who initially appeared to have AI. Had these patients had AI, their prognosis would have been grave.
As the serum cortisol response to ACTH decreases, mortality rate increases. Table 6 summaries baseline and delta cortisol response as well as hospital mortality rate. The decreased delta cortisol response may be a marker for poor prognosis. Plotting the mean delta cortisol response in each study vs. the study mortality rate demonstrates a significant correlation between delta cortisol response and mortality rate (r ϭ .754, p Ͻ .01). The smaller the delta cortisol response to a 250-g dose of ACTH, the greater the mortality rate observed (Fig. 1) .
Earlier research in patients with SIRS demonstrated that bacteremic patients (n ϭ 27) had a similar baseline cortisol concentration to the nonbacteremic (n ϭ 74) patients (25.4 Ϯ 1.9 vs. 25.1 Ϯ 2.5 g/dL, mean Ϯ SEM, respectively). However, the bacteremic patients had a reduced delta cortisol response to ACTH (14.7 Ϯ 2.2 vs. 18.9 Ϯ 1.2 g/dL, p Ͻ .05, respectively) (6). These data, along with the data in Table  6 , suggest that bacteremia may be associated adrenal dysfunction and a reduced cortisol response to ACTH. Unlike the absolute cutoff of 20 g/dL of serum cortisol for the diagnosis of AI, a reduced delta cortisol response should only be used in the definition of adrenal dysfunction. The exact cutoff has not been established, but the cortisol response to diagnose adrenal dysfunction is likely between 6 and 13 g/dL. Adrenal dysfunction resolves after recovery from sepsis (9) . The cortisol delta response to 250 g of ACTH increases from an average of 7.7 g/dL to 14.7 g/dL. Basal cortisol concentrations remain similar over the approximate 30-day time period (18.8 vs. 18.9 g/dL) (9) .
A recent review suggests that glucocorticoid therapy could be initiated in patients with septic shock if a random cortisol concentration is Ͻ15 g/dL (34) . If the random cortisol concentration is between 15 and 34 g/dL, the response to an ACTH stimulation test may identify who has hypoadrenalism. For example, if the response is Ͻ9 g/dL, then hypoadrenalism is likely and physiological glucocorticoid treatment may be helpful (34) . In the current study, 21 patients had a baseline cortisol concentration of Ͻ15 g/dL. One third (n ϭ 7) of these failed to increase their cortisol to above 19.9 g/dL. They met the criteria of AI. However, 14 patients increased their cortisol concentration above 19.9 g/dL. All 14 of these patients increased their cortisol concentration by Ͼ9 g/dL. This would suggest that a random cortisol concentration of Ͻ15 g/dL may identify potential patients with sepsis who have primary or secondary AI, but the majority (2/3) do not have AI. Other investigators suggest that a cortisol concentration (Ͻ20 g/dL) may "warrant a Table 6 as septic shock and bacteremia. The other four points are from studies of systemic inflammatory response syndrome and intensive care unit patients from Table 6. For example, at a delta cortisol of 13 g/dL, the mortality rate is 50%. At a delta cortisol of 0 g/dL, the mortality rate is 74%, and at a delta cortisol of 26 g/dL, the mortality rate would be only 26%. The regression equation for hospital mortality is % mortality ϭ Ϫ1.84 ϫ delta cortisol ϩ 73.6. trial of replacement doses of corticosteroids" (35) . Thirty of the 100 patients in the current study had a baseline cortisol concentration of Ͻ20 g/dL. Of the 30 with a baseline Ͻ20 g/dL, only nine had AI. The other 21 patients increased their cortisol concentration to Ͼ19.9 g/dL. Of the 21 patients who increased their cortisol, only four met the adrenal dysfunction criteria of a delta cortisol response Ͻ9 g/dL.
While the use of a random cortisol concentration may identify some patients at risk, many have normal adrenal function. For those with sepsis but not shock, additional criteria may be needed to identify those who would benefit from corticosteroid therapy.
CONCLUSION
These data demonstrate that 9% of adults with sepsis are unable to increase serum cortisol concentrations to Ն20 g/dL after a 250-g ACTH stimulation test. This was due to pituitary disease (n ϭ 4) and adrenal insufficiency or adrenal dysfunction (n ϭ 5). Hypotension was not associated with a reduced cortisol response to ACTH so that other factors may have been responsible for the reduced cortisol response. A normal aldosterone response to ACTH in four of the patients indicates that the defect is at the hypothalamic-pituitary axis. Five patients (5%) failed to normally increase cortisol and aldosterone concentrations after ACTH administration. Although it is likely that these patients have adrenal dysfunction, a rapid decrease in ACTH concentrations by days 4 -6 in sepsis may obscure the diagnosis of AI in patients with sepsis. Since three of five patients recovered from the sepsis without treatment with glucocorticoids, it seems unlikely that permanent AI was present in these patients. It is likely that adrenal dysfunction exists in many patients with sepsis, and when all cortisol concentrations are Ͻ20 g/dL, then the diagnosis of AI or adrenal insufficiency becomes difficult. Unlike the difficulty in determining AI from adrenal dysfunction, it is clear that approximately 4% of septic patients present with occult pituitary disease or secondary AI.
